The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Mammalian cells may consume bacteria-killing viruses to promote cellular health
Pharma & Human Health

Mammalian cells may consume bacteria-killing viruses to promote cellular health

NOV 9, 2023
Canada approves gut-brain axis health claims for Chr. Hansen probiotic strain
Biotics and Supplements

Canada approves gut-brain axis health claims for Chr. Hansen probiotic strain

NOV 8, 2023
MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT
Clinical & Manufacturing

MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT

NOV 7, 2023
Seres Therapeutics announces strategic restructuring and third quarter financial results including VOWST™ net sales
Finance

Seres Therapeutics announces strategic restructuring and third quarter financial results including VOWST™ net sales

NOV 6, 2023
Atopic dermatitis: Viruses discovered as new therapy option
Pharma & Human Health

Atopic dermatitis: Viruses discovered as new therapy option

NOV 6, 2023
Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors
Biotics and Supplements

Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors

NOV 6, 2023
Using a novel computational approach, researchers confirm microbial diversity is wilder than ever.
Editor's Choice

Using a novel computational approach, researchers confirm microbial diversity is wilder than ever.

OCT 30, 2023
EMA adopts guidelines on veterinary medicinal products for phage therapy.
Animal Health

EMA adopts guidelines on veterinary medicinal products for phage therapy.

OCT 29, 2023
Fonterra and APC Microbiome Ireland have announce the establishment of a new microbiome research centre
Finance

Fonterra and APC Microbiome Ireland have announce the establishment of a new microbiome research centre

OCT 27, 2023
Pharmacomicrobiomics: The universe of microbiome-drug interactions
Editor's Choice

Pharmacomicrobiomics: The universe of microbiome-drug interactions

OCT 26, 2023
Lallemand Health Solutions is strengthening its strategic position in the microbiome field through CDMO operations
Finance

Lallemand Health Solutions is strengthening its strategic position in the microbiome field through CDMO operations

OCT 20, 2023